Author

Y. D. Jeong

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Evolutionary Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:statistical model· 2 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:virus· 1

Frequent Co-Authors

K. S. Kim· 3 shared S. Iwami· 3 shared H. Park· 2 shared S. Iwanami· 2 shared A. H. Azam· 1 shared D. Akazawa· 1 shared E.-S. Park· 1 shared H. Ebihara· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersMicrobiology

K. S. Kim

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Isolation may select for earlier and higher peak viral load but shorter duration in SARS-CoV-2 evolution

J. Sunagawa, K. S. Kim, H. Park, R. Komorizono, S. Choi, L. R. Torres, J. Woo, Y. D. Jeong, W. S. Hart, R. N. Thompson, K. Aihara, S. Iwami, R. Yamaguchi

This study shows isolation measures during the pandemic selected for SARS-CoV-2 variants with earlier and higher peak viral loads but shorter infection duration.

bioRxiv · Feb 23, 2023Evolutionary Biology

Potential anti-monkeypox virus activity of atovaquone, mefloquine, and molnupiravir, and their potential use as treatments

D. Akazawa, H. Ohashi, T. Hishiki, T. Morita, S. Iwanami, K. S. Kim, Y. D. Jeong, E.-S. Park, M. Kataoka, K. Shionoya, J. Mifune, K. Tsuchimoto, S. Ojima, A. H. Azam, S. Nakajima, , K. Watashi

This study identifies atovaquone, mefloquine, and molnupiravir as potential anti-monkeypox virus drugs, with atovaquone showing enhanced efficacy when combined with tecovirimat.

bioRxiv · Aug 2, 2022 · PreprintMicrobiology

Characterization of various remdesivir-resistant mutations of SARS-CoV-2 by mathematical modeling and molecular dynamics simulation.

S. Torii, K. S. Kim, J. Koseki, R. Suzuki, S. Iwanami, Y. Fujita, Y. D. Jeong, Y. Matsuura, T. Shimamura, S. Iwami, T. Fukuhara

This study identifies remdesivir-resistant SARS-CoV-2 mutations using viral reconstruction, mathematical modeling, and molecular dynamics simulations, showing mutations reduce antiviral activity without increasing viral production.

bioRxiv · Feb 22, 2022 · PreprintMicrobiology